Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

BMY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.09%

Insider Buying (Last 12 Months): $672,994.06

Insider Selling (Last 12 Months): $4,525,215.08

Bristol-Myers Squibb Insider Trading History Chart

Bristol-Myers Squibb Share Price & Price History

^$48.93

▲ +0.63 (1.30%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Bristol-Myers Squibb Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2023	Christopher S. Boerner	CEO	Buy	2,000	$49.78	$99,560.00	82,672
11/28/2023	Christopher S. Boerner	CEO	Buy	3,071	$48.86	$150,049.06	79,384
11/20/2023	Theodore R. Samuels, II	Director	Buy	8,500	$49.81	$423,385.00	35,500
8/24/2023	Ann Powell	EVP	Sell	17,986	$61.25	$1,101,642.50	27,868
8/3/2023	Robert M. Plenge	EVP	Sell	732	$61.14	$44,754.48	6,584
5/3/2023	Rupert Vessey	EVP	Sell	50,385	$67.06	$3,378,818.10	47,751
2/6/2023	Ann Powell	EVP	Sell	11,183	$74.69	$835,258.27	23,043
2/6/2023	Giovanni Caforio	CEO	Sell	240,000	$74.65	$17,916,000.00	236,104
11/9/2022	Ann Powell	EVP	Sell	16,250	$80.45	$1,307,312.50	34,226
11/7/2022	Rupert Vessey	EVP	Sell	45,910	$78.88	$3,621,380.80	57,079
9/20/2022	Giovanni Caforio	CEO	Sell	25,000	$69.71	$1,742,750.00	476,104
9/15/2022	Giovanni Caforio	CEO	Sell	50,000	$71.84	$3,592,000.00	501,104
9/14/2022	Ann Powell	EVP	Sell	25,000	$70.75	$1,768,750.00	50,476
9/13/2022	David V. Elkins	CFO	Sell	133,951	$71.30	$9,550,706.30	100,460
6/13/2022	Giovanni Caforio	CEO	Sell	30,000	$74.04	$2,221,200.00	551,104
6/6/2022	Sandra Leung	EVP	Sell	65,000	$74.89	$4,867,850.00	308,627
3/21/2022	Giovanni Caforio	CEO	Sell	25,000	$71.52	$1,788,000.00
3/16/2022	Rupert Vessey	EVP	Sell	74,559	$69.25	$5,163,210.75
3/14/2022	Christopher S. Boerner	EVP	Sell	29,532	$69.20	$2,043,614.40
3/14/2022	Karen Murphy Santiago	SVP	Sell	6,577	$69.19	$455,062.63
2/24/2022	Giovanni Caforio	CEO	Sell	30,000	$67.00	$2,010,000.00
11/24/2021	Paul von Autenried	EVP	Sell	17,353	$56.92	$987,732.76
11/22/2021	Paul von Autenried	EVP	Sell	18,363	$57.17	$1,049,812.71
9/20/2021	Giovanni Caforio	CEO	Sell	25,000	$60.64	$1,516,000.00
8/12/2021	David V. Elkins	CFO	Sell	99,691	$66.95	$6,674,312.45
5/10/2021	Joseph Eid	SVP	Sell	1,118	$65.00	$72,670.00	8,069
5/10/2021	Louis S Schmukler	EVP	Sell	15,000	$65.25	$978,750.00	31,956
5/5/2021	Adam Dubow	SVP	Sell	3,119	$64.21	$200,270.99	16,243
5/5/2021	Rupert Vessey	EVP	Sell	30,546	$64.29	$1,963,802.34	45,139

Secret Bull Market Starts in This Unusual Sector

From Altimetry | Ad

Click for my No. 1 investment, all free of charge, click here.

SEC Filings (Institutional Ownership Changes) for Bristol-Myers Squibb (NYSE:BMY)

76.41% of Bristol-Myers Squibb stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bristol-Myers Squibb Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/20/2024	Maryland State Retirement & Pension System	159,870	$8.67M	0.2%	+0.9%	0.008%
4/20/2024	Cohen Investment Advisors LLC	7,132	$0.39M	0.3%	-2.8%	0.000%
4/19/2024	FORVIS Wealth Advisors LLC	25,824	$1.40M	0.0%	-4.7%	0.001%
4/19/2024	Everett Harris & Co. CA	12,770	$0.69M	0.0%	-3.4%	0.001%
4/19/2024	Marshall Financial Group LLC	28,437	$1.54M	0.4%	+8.1%	0.001%
4/19/2024	FCG Investment Co	8,212	$0.45M	0.4%	N/A	0.000%
4/19/2024	New Century Financial Group LLC	20,938	$1.14M	0.8%	N/A	0.001%
4/19/2024	Park Edge Advisors LLC	15,877	$0.86M	0.2%	-4.9%	0.001%
4/19/2024	Tempus Wealth Planning LLC	11,318	$0.61M	0.3%	+190.2%	0.001%
4/19/2024	Accel Wealth Management	4,934	$0.27M	0.1%	+19.0%	0.000%
4/19/2024	Legacy Wealth Asset Management LLC	9,860	$0.54M	0.1%	+5.9%	0.000%
4/19/2024	Uncommon Cents Investing LLC	10,305	$0.56M	0.2%	+13.9%	0.001%
4/19/2024	First Trust Direct Indexing L.P.	22,320	$1.21M	0.1%	+52.1%	0.001%
4/19/2024	Cornerstone Wealth Management LLC	15,392	$0.84M	0.1%	+6.6%	0.001%
4/19/2024	Kovack Advisors Inc.	30,489	$1.65M	0.2%	+32.4%	0.002%
4/19/2024	DMC Group LLC	6,597	$0.36M	0.3%	-3.5%	0.000%
4/19/2024	Hudson Capital Management LLC	68,494	$3.71M	1.3%	+10.7%	0.003%
4/19/2024	Abundance Wealth Counselors	26,690	$1.45M	0.3%	+26.9%	0.001%
4/19/2024	Westside Investment Management Inc.	6,761	$0.37M	0.1%	-5.5%	0.000%
4/19/2024	Norden Group LLC	236,606	$12.83M	0.1%	+2,125.2%	0.012%
4/19/2024	Arvest Investments Inc.	31,978	$1.73M	0.3%	-14.5%	0.002%
4/19/2024	Meadow Creek Wealth Advisors LLC	5,945	$0.32M	0.2%	+37.3%	0.000%
4/19/2024	Lake Street Private Wealth LLC	17,447	$0.95M	0.1%	+14.4%	0.001%
4/19/2024	Valley National Advisers Inc.	9,241	$0.50M	0.1%	-17.2%	0.000%
4/19/2024	E&G Advisors LP	5,551	$0.30M	0.1%	+5.7%	0.000%
4/19/2024	Redmont Wealth Advisors LLC	858	$47K	0.1%	N/A	0.000%
4/19/2024	State of Alaska Department of Revenue	502,222	$27.24M	0.3%	-8.6%	0.025%
4/19/2024	Albion Financial Group UT	1,985	$0.11M	0.0%	+60.0%	0.000%
4/19/2024	Carret Asset Management LLC	56,617	$3.07M	0.4%	-1.3%	0.003%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	5,074,466	$275.19M	0.2%	-9.3%	0.250%
4/18/2024	Plimoth Trust Co. LLC	31,677	$1.72M	0.5%	-1.4%	0.002%
4/18/2024	SeaCrest Wealth Management LLC	15,817	$0.86M	0.1%	-58.7%	0.001%
4/18/2024	Naviter Wealth LLC	23,719	$1.29M	0.2%	+64.3%	0.001%
4/18/2024	Quattro Financial Advisors LLC	45,000	$2.44M	0.7%	+88,135.3%	0.002%
4/18/2024	State of Michigan Retirement System	1,924,733	$104.38M	0.6%	+208.3%	0.095%
4/18/2024	MV Capital Management Inc.	1,989	$0.11M	0.0%	-17.6%	0.000%
4/18/2024	Capital Advisors Ltd. LLC	5,395	$0.29M	0.0%	-36.0%	0.000%
4/18/2024	Woodmont Investment Counsel LLC	16,919	$0.92M	0.1%	-9.1%	0.001%
4/18/2024	Synergy Asset Management LLC	52,578	$2.85M	0.5%	-3.1%	0.003%
4/18/2024	Westhampton Capital LLC	9,667	$0.54M	0.3%	+63.2%	0.000%
4/18/2024	Farmers & Merchants Investments Inc.	147,589	$8M	0.3%	-4.0%	0.007%
4/18/2024	Cullinan Associates Inc.	109,338	$5.93M	0.3%	-4.3%	0.005%
4/18/2024	FARMERS & MERCHANTS TRUST Co OF LONG BEACH	3,935	$0.21M	0.1%	-5.7%	0.000%
4/18/2024	Allspring Global Investments Holdings LLC	1,507,928	$81.78M	0.1%	-13.3%	0.074%
4/18/2024	AlphaMark Advisors LLC	22,605	$1.23M	0.4%	+2.3%	0.001%
4/18/2024	Dominguez Wealth Management Solutions Inc.	20,990	$1.14M	0.9%	+6.0%	0.001%
4/18/2024	Hexagon Capital Partners LLC	15,677	$0.85M	0.2%	+11.7%	0.001%
4/18/2024	Park Place Capital Corp	8,739	$0.47M	0.2%	+139.0%	0.000%
4/18/2024	Claro Advisors LLC	21,779	$1.18M	0.2%	+15.5%	0.001%
4/18/2024	Talbot Financial LLC	78,269	$4.25M	0.6%	+7.3%	0.004%
4/18/2024	Miracle Mile Advisors LLC	96,800	$5.25M	0.1%	+1,238.5%	0.005%
4/18/2024	Little House Capital LLC	18,271	$0.99M	0.3%	+33.1%	0.001%
4/18/2024	Udine Wealth Management Inc.	33,571	$1.82M	1.3%	N/A	0.002%
4/18/2024	BKM Wealth Management LLC	4,924	$0.27M	0.1%	+151.1%	0.000%
4/18/2024	Diversified Trust Co	71,466	$3.88M	0.1%	+76.7%	0.004%
4/18/2024	Aviance Capital Partners LLC	96,494	$5.23M	0.8%	+22.0%	0.005%
4/18/2024	Mirador Capital Partners LP	45,484	$2.47M	0.5%	+4.3%	0.002%
4/18/2024	Chapin Davis Inc.	22,544	$1.22M	0.4%	+22.6%	0.001%
4/18/2024	Successful Portfolios LLC	5,360	$0.29M	0.2%	-4.2%	0.000%
4/18/2024	Barry Investment Advisors LLC	11,352	$0.62M	0.2%	-2.7%	0.001%
4/18/2024	Chatham Capital Group Inc.	21,595	$1.17M	0.2%	-2.3%	0.001%
4/17/2024	Sandy Cove Advisors LLC	4,615	$0.25M	0.1%	+14.0%	0.000%
4/17/2024	Dumont & Blake Investment Advisors LLC	9,159	$0.50M	0.1%	-4.7%	0.000%
4/17/2024	Trilogy Capital Inc.	60,484	$3.28M	0.2%	+14.5%	0.003%
4/17/2024	Red Door Wealth Management LLC	9,451	$0.51M	0.1%	+14.7%	0.000%
4/17/2024	Cornerstone Wealth Group LLC	12,915	$0.70M	0.1%	+198.1%	0.001%
4/17/2024	New Mexico Educational Retirement Board	126,734	$6.87M	0.2%	+15.9%	0.006%
4/17/2024	Founders Financial Securities LLC	12,400	$0.67M	0.1%	N/A	0.001%
4/17/2024	Guidance Capital Inc.	9,939	$0.54M	0.2%	-7.6%	0.000%
4/17/2024	Atticus Wealth Management LLC	2,816	$0.15M	0.1%	-38.0%	0.000%
4/17/2024	Symphony Financial Ltd. Co.	7,109	$0.39M	0.1%	-34.6%	0.000%
4/17/2024	Vicus Capital	3,873	$0.21M	0.0%	N/A	0.000%
4/17/2024	Ridgecrest Wealth Partners LLC	9,675	$0.53M	0.3%	-4.0%	0.000%
4/17/2024	Alpha Omega Wealth Management LLC	36,971	$2.01M	0.4%	-1.8%	0.002%
4/17/2024	Chemung Canal Trust Co.	41,012	$2.22M	0.4%	+4.1%	0.002%
4/17/2024	Romano Brothers AND Company	93,402	$5.07M	0.7%	-6.2%	0.005%
4/17/2024	Baker Ellis Asset Management LLC	6,130	$0.33M	0.0%	-6.1%	0.000%
4/17/2024	First Bank & Trust	20,207	$1.10M	0.2%	N/A	0.001%
4/17/2024	Saratoga Research & Investment Management	3,704	$0.20M	0.0%	N/A	0.000%
4/17/2024	Grimes & Company Inc.	380,641	$20.64M	0.6%	+10.3%	0.019%
4/17/2024	WoodTrust Financial Corp	13,726	$0.74M	0.1%	+38.4%	0.001%
4/17/2024	Burns J W & Co. Inc. NY	40,476	$2.20M	0.3%	-23.9%	0.002%
4/17/2024	Hennion & Walsh Asset Management Inc.	60,452	$3.28M	0.2%	-4.9%	0.003%
4/16/2024	Trust Co. of Virginia VA	26,567	$1.44M	0.1%	-8.5%	0.001%
4/16/2024	Opinicus Capital Inc.	13,599	$0.74M	0.7%	+64.2%	0.001%
4/16/2024	Viewpoint Capital Management LLC	28,346	$1.54M	1.0%	-7.8%	0.001%
4/16/2024	Occidental Asset Management LLC	8,498	$0.46M	0.1%	-14.0%	0.000%
4/16/2024	Independence Bank of Kentucky	10,556	$0.57M	0.2%	+3.0%	0.001%
4/16/2024	OneAscent Financial Services LLC	9,653	$0.52M	0.1%	-3.2%	0.000%
4/16/2024	Webster Bank N. A.	25,700	$1.39M	0.2%	-3.9%	0.001%
4/16/2024	OneAscent Wealth Management LLC	5,992	$0.33M	0.1%	+5.0%	0.000%
4/16/2024	KRS Capital Management LLC	14,260	$0.77M	0.6%	-1.4%	0.001%
4/16/2024	New England Research & Management Inc.	50,007	$2.71M	1.3%	+10.3%	0.002%
4/16/2024	Kathmere Capital Management LLC	4,096	$0.22M	0.0%	N/A	0.000%
4/16/2024	Calton & Associates Inc.	10,786	$0.59M	0.3%	N/A	0.001%
4/16/2024	Ameliora Wealth Management Ltd.	32,144	$1.74M	0.8%	+4.3%	0.002%
4/16/2024	Norwood Financial Corp	3,053	$0.17M	0.2%	+17.3%	0.000%
4/16/2024	Pinnacle Bancorp Inc.	3,326	$0.18M	0.1%	+20.5%	0.000%
4/16/2024	Atlantic Union Bankshares Corp	34,500	$1.87M	0.2%	-1.8%	0.002%
4/16/2024	Register Financial Advisors LLC	4,788	$0.26M	0.1%	N/A	0.000%

Data available starting January 2016

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $48.93

$48.12

$49.05

50 Day Range

MA: $51.23

$47.83

$54.40

52 Week Range

Now: $48.93

$47.58

$70.93

Volume

10,303,913 shs

Average Volume

10,788,345 shs

Market Capitalization

$99.17 billion

P/E Ratio

12.68

Dividend Yield

4.97%

Beta

0.39

Who are the company insiders with the largest holdings of Bristol-Myers Squibb?: Bristol-Myers Squibb's top insider shareholders include:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
David V Elkins (CFO)
Christopher S Boerner (CEO)
Rupert Vessey (EVP)
Ann Powell (EVP)
Theodore R Samuels II (Director)
Robert M Plenge (EVP)
Learn More about top insider investors at Bristol-Myers Squibb.
Who are the major institutional investors of Bristol-Myers Squibb?: Bristol-Myers Squibb's top institutional shareholders include:
Sumitomo Mitsui Trust Holdings Inc. — 0.25%
State of Michigan Retirement System — 0.09%
Los Angeles Capital Management LLC — 0.09%
Douglas Lane & Associates LLC — 0.09%
Allspring Global Investments Holdings LLC — 0.07%
Meyer Handelman Co. — 0.03%
Learn More about top institutional investors of Bristol-Myers Squibb stock.
Which institutional investors are selling Bristol-Myers Squibb stock?: During the last quarter, BMY stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
Gateway Investment Advisers LLC
Allspring Global Investments Holdings LLC
Alaska Permanent Fund Corp
Los Angeles Capital Management LLC
Welch Group LLC
State of Alaska Department of Revenue
IMC Chicago LLC
In the last year, company insiders that have sold Bristol-Myers Squibb company stock include:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
David V Elkins (CFO)
Learn More investors selling Bristol-Myers Squibb stock.
Which institutional investors are buying Bristol-Myers Squibb stock?: During the last quarter, BMY stock was purchased by institutional investors including:
State of Michigan Retirement System
Norden Group LLC
TB Alternative Assets Ltd.
Global Assets Advisory LLC
Miracle Mile Advisors LLC
Wealth Enhancement Advisory Services LLC
Douglas Lane & Associates LLC
Quattro Financial Advisors LLC
During the last year, these company insiders have bought Bristol-Myers Squibb stock:
Giovanni Caforio (CEO)
Sandra Leung (EVP)
Learn More investors buying Bristol-Myers Squibb stock.